DrugPatentWatch Database Preview
BOTOX Drug Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Summary for Tradename: BOTOX
| Patents: | 42 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Drug Prices: | Drug price information for BOTOX |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for BOTOX |
Pharmacology for BOTOX
| Mechanism of Action | Acetylcholine Release Inhibitors |
Company Disclosures: US Patents for BOTOX
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allergan | BOTOX | onabotulinumtoxina | VIAL; SINGLE-USE | 103000 | 001 | 1991-12-09 | Start Trial | The Regents of the University of Colorado (Boulder, CO) | 2017-07-15 | RX | company | |
| Allergan | BOTOX | onabotulinumtoxina | VIAL; SINGLE-USE | 103000 | 001 | 1991-12-09 | Start Trial | Allergan, Inc. (Irvine, CA) | 2013-12-28 | RX | company | |
| Allergan | BOTOX | onabotulinumtoxina | VIAL; SINGLE-USE | 103000 | 001 | 1991-12-09 | Start Trial | Allergan, Inc. (Irvine, CA) | 2013-12-28 | RX | company | |
| Allergan | BOTOX | onabotulinumtoxina | VIAL; SINGLE-USE | 103000 | 001 | 1991-12-09 | Start Trial | Allergan, Inc. (Irvine, CA) | 2013-12-28 | RX | company | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
Patent Text Search: US Patents for BOTOX
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allergan | BOTOX | onabotulinumtoxina | VIAL; SINGLE-USE | 103000 | 001 | 1991-12-09 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2033-03-11 | RX | search | |
| Allergan | BOTOX | onabotulinumtoxina | VIAL; SINGLE-USE | 103000 | 001 | 1991-12-09 | Start Trial | NANOMED SKINCARE, INC. (Cupertino, CA) | 2039-02-26 | RX | search | |
| Allergan | BOTOX | onabotulinumtoxina | VIAL; SINGLE-USE | 103000 | 001 | 1991-12-09 | Start Trial | Allergan, Inc. (Irvine, CA) | 2039-02-26 | RX | search | |
| Allergan | BOTOX | onabotulinumtoxina | VIAL; SINGLE-USE | 103000 | 001 | 1991-12-09 | Start Trial | 2034-03-16 | RX | search | ||
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for BOTOX
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 3238154 | Start Trial |
| Hong Kong | 1033274 | Start Trial |
| Japan | 2010202659 | Start Trial |
| Hong Kong | 1070831 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for BOTOX
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 92055 | Luxembourg | Start Trial | PRODUCT NAME: TOXINE BOTULIQUE DE CLOSTRIDIUM BOTULINUM |
| C300564 | Netherlands | Start Trial | PRODUCT NAME: BOTULINUM TOXINE; NAT. REGISTRATION NO/DATE: RVG 32957RVG 17379RVG 32958 2012270627; FIRST REGISTRATION: NL 25449 20110822 |
| C02145629/01 | Switzerland | Start Trial | FORMER OWNER: THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE, US |
| 92250 | Luxembourg | Start Trial | PRODUCT NAME: TOXINE BOTULIQUE DE TYPE A DE CLOSTRIDIUM BOTULINUM |
| >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
